Mary Kay Fenton - Insider Trading & Ownership

Entity
Individual
Location
Achillion Pharmaceuticals, 300 George Street, New Haven, CT
Summary
The estimated net worth of Mary Kay Fenton is at least $1.91M dollars as of February 21, 2025. Mary Kay Fenton is the Chief Financial Officer of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $1.16M. Mary Kay Fenton is the Chief Financial Officer of Cullinan Therapeutics, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $751K.
All Insider Reports
All Insider Reports

Ownership of Mary Kay Fenton

Insider Transactions Reported by Mary Kay Fenton:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.